These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4154157)

  • 1. Reduced serum somatomedin activity in patients with chronic liver disease.
    Wu A; Grant DB; Hambley J; Levi AJ
    Clin Sci Mol Med; 1974 Oct; 47(4):359-66. PubMed ID: 4154157
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of blood ammonia level in liver diseases].
    Engelmann L
    Z Gesamte Inn Med; 1970 Dec; 25(23):1049-55. PubMed ID: 4104436
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of gamma glutamyl transpeptidase activity in human serum. Its use in oncology.
    Delarue JC; Sancho H; Rouesse J; Bohuon C
    Biomedicine; 1973 Mar; 18(2):152-8. PubMed ID: 4147288
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Normotest and Thrombotest, coagulation tests in hepatocellular disease.
    Hillenbrand P; Sherlock S
    Scand J Gastroenterol Suppl; 1973; 19():125-31. PubMed ID: 4123935
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum gamma glutamyl transpeptidase in hepatobiliary diseases. Comparison with alkaline phosphatase and aryl amidase].
    Schlaeger R; Schenzer R; Kattermann R
    Med Klin; 1972 Apr; 67(15):521-6. PubMed ID: 4340792
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serochemical differential diagnosis of chronic liver diseases by means of discrimination analysis with special reference to the mesenchyma].
    van Husen N; Eberhardt G; Gerlach U; Intorp HW; Oberwittler W
    Z Gastroenterol; 1974 Jul; 12(5):327-34. PubMed ID: 4138663
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
    Collazos J
    Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of liver function tests in hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Thambyrajah V; Timor J
    Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ergometric studies of body tolerance in patients with chronic liver disease].
    Franken FH; Wiechers B
    Dtsch Med Wochenschr; 1973 Mar; 98(11):528-31. PubMed ID: 4694994
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
    Soresi M; Cervello M; Lipani G; Carroccio A; Cartabellotta A; Marasà L; Casto C; Virruso L; Montalto G
    Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):805-9. PubMed ID: 9282280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor II in chronic liver disease.
    Hayakawa T; Kondo T; Shibata T; Kitagawa M; Ono H; Sakai Y; Kato K; Katada N; Sugimoto Y; Takeichi M
    Dig Dis Sci; 1989 Mar; 34(3):338-42. PubMed ID: 2537715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum gamma-glutamyl-transferase (transpeptidase) and histological liver damage in alcoholism.
    Wu A; Slavin G; Levi AJ
    Am J Gastroenterol; 1976 Apr; 65(4):318-23. PubMed ID: 7137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA; Braconier JH; Eriksson O
    Scand J Gastroenterol Suppl; 1973; 19():83-91. PubMed ID: 4515643
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver enzyme alteration: a guide for clinicians.
    Giannini EG; Testa R; Savarino V
    CMAJ; 2005 Feb; 172(3):367-79. PubMed ID: 15684121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of Mallory bodies in the progression of fatty liver into cirrhosis.
    Christoffersen P; Juhl E
    Acta Pathol Microbiol Scand A; 1974 Jul; 82(4):483-6. PubMed ID: 4137298
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical changes in patients with combined chronic schistosomiasis and viral hepatitis C infections.
    Fahim FA; Esmat AY; Hassan GK; Abdel-Bary A
    Dis Markers; 2000; 16(3-4):111-8. PubMed ID: 11381190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-androgen imbalance in hepatic cirrhosis. Studies in 13 male patients.
    Chopra IJ; Tulchinsky D; Greenway FL
    Ann Intern Med; 1973 Aug; 79(2):198-203. PubMed ID: 4726534
    [No Abstract]   [Full Text] [Related]  

  • 20. [Critical evaluation of the serum enzymatic diagnosis of liver diseases].
    Sposito M; Albertini Petroni V; Hassan G; Marinucci G; Valeri L
    Quad Sclavo Diagn; 1971 Dec; 7(4):1036-49. PubMed ID: 4144704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.